Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Needle-Free sedation: new study tests nasal spray for painful procedures

NCT ID NCT07166666

First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 30 times

Summary

This study compares three sedative drugs given as a nasal spray (atomized) to help people relax during medical procedures. It includes 128 participants aged 2 to 60 years. Researchers will measure how well the sedation works, how fast it starts, recovery time, and any side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEDATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • dr.Suad al baluish

    Muscat, Oman

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Midazolam, fentanyl, and dexmedetomidine given via a nasal atomizer

What this could lead to

If successful, this could show that atomized sedation is effective and safe for both children and adults, offering a needle-free option for medical procedures.

What could go wrong

This is an early-stage study with only 128 participants, so results may not apply to everyone. Side effects like breathing problems or allergic reactions are possible.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.